All In Biotech

Drug Trial Radar · NCT03235544

A Study of INCB050465 in Relapsed or Refractory Mantle Cell Lymphoma Previously Treated With or Without a Bruton's Tyrosine Kinase (BTK) Inhibitor

A Phase 2, Open-Label, 2-Cohort, Multicenter Study of INCB050465, a PI3Kδ Inhibitor, in Relapsed or Refractory Mantle Cell Lymphoma Previously Treated With or Without a BTK Inhibitor (CITADEL-205)

Last checked: Nov 19, 2026Latest source record: Mar 18, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

162

Actual

Start

Nov 20, 2017

Primary completion

Apr 30, 2024

Study completion Apr 30, 2024

Sponsor

Lead sponsor
Incyte CorporationIncyte (INCY)
Sponsor type
Industry
First posted
Aug 1, 2017

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Non randomized
Model
Sequential
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a Phase 2, open-label, 2-cohort study designed to evaluate the efficacy and safety of 2 parsaclisib treatment regimens in participants with relapsed or refractory mantle cell lymphoma (MCL) previously treated either with or without a Bruton's tyrosine kinase (BTK) inhibitor.

Conditions

  • Lymphoma

Interventions

  • ParsaclisibDrug

    Parsaclisib tablets administered orally with water and without regard to food.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Objective Response Rate (ORR)Time frame: Up to 1016 days

Locations

103 sites in 11 countries. Site status is shown where the registry gives one.

  • University of Alabama At Birmingham Comprehensive Cancer Center

    Birmingham, Alabama

  • St. Joseph Heritage Healthcare

    Santa Rosa, California

  • Rocky Mountain Cancer Center-Aurora

    Aurora, Colorado

  • Asclepes Research Centers

    Brooksville, Florida

  • Moffitt Cancer Center

    Tampa, Florida

  • Bond & Steele Clinic, P.A.

    Winter Haven, Florida

  • Rush University Medical Center

    Chicago, Illinois

  • Loyola University Medical Center

    Maywood, Illinois

  • Illinois Cancer Specialists

    Niles, Illinois

  • Hattiesburg Clinic Hematology

    Hattiesburg, Mississippi

  • Clinical Research Alliance, Inc.

    New Hyde Park, New York

  • Duke University Medical Center

    Durham, North Carolina

  • Oncology Hematology Care, Inc.

    Cincinnati, Ohio

  • Willamette Valley Cancer Institute

    Eugene, Oregon

  • Kaiser Permanente - Northwest

    Portland, Oregon

  • Gettysburg Cancer Center

    Gettysburg, Pennsylvania

  • Texas Oncology

    Austin, Texas

  • Texas Oncology San Antonio

    San Antonio, Texas

  • Renovatio Clinical

    The Woodlands, Texas

  • Texas Oncology - Tyler

    Tyler, Texas

  • Yakima Valley Memorial Hospital/North Star

    Yakima, Washington

  • Institut Jules Bordet

    Brussels, Belgium

  • Hopital de Jolimont

    La Louvière, Belgium

  • Universitaire Ziekenhuis Leuven - Gasthuisberg

    Leuven, Belgium

  • Universitair Ziekenhuis Gent

    Ghent, Oost-Vlaanderen, Belgium

  • Fakultni Nemocnice Hradec Kralove

    Hradec Králové, Czechia

  • Fakultni Nemocnice Kralovske Vinohadry, Interni Hematologicka Klinika

    Prague, Czechia

  • Charles University General Hospital

    Prague, Czechia

  • Fakultni Nemocnice Kralovske Vinohrady

    Prague, Czechia

  • Aalborg University Hospital

    Aalborg, Denmark

  • Aarhus Universitets Hospital

    Aarhus, Denmark

  • Odense Universitetshospital (Ouh) (Odense University Hospital)

    Odense C, Denmark

  • Zealand University Hospital

    Roskilde, Denmark

  • Avicenne Hospital

    Bobigny, France

  • Chu de Clermont - Ferrand- Hospital Estaing

    Clermont-Ferrand, France

  • Centre Hospitalier Universitaire Henri Mondor

    Créteil, France

  • University Hospital Grenoble

    Grenoble, France

  • Centre Hospitalier Departemental - La-Roche-Sur-Yon - Les Oudairies

    La Roche-sur-Yon, France

  • Centre Hospitalier Universitaire de Grenoble

    La Tronche, France

  • Centre Hospitalier de Versailles

    Le Chesnay, France

Showing 40 of 103 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.